51144-001 : Tukysa 50 mg Oral Tablet
| NDC: | 51144-001 |
| Labeler: | Seattle Genetics, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Tukysa |
| Dosage Form: | Oral Tablet |
| Application #: | NDA213411 |
| Rev. Date: |
Appearance:
| Markings: | TUC;50 |
| Shapes: |
Round |
| Colors: |
 Yellow |
| Size (mm): | 8 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 51144-001-60: 60 TABLET IN 1 BOTTLE (51144‑001‑60)
Active Ingredients:
- Tucatinib
Dosage Strength:
- 50 mg
Inactive Ingredients:
- Copovidone K25-31
- Crospovidone (120 .mu.m)
- Sodium Chloride
- Potassium Chloride
- Sodium Bicarbonate
- Silicon Dioxide
- Magnesium Stearate
- Microcrystalline Cellulose 102
- Polyvinyl Alcohol, Unspecified
- Titanium Dioxide
- Polyethylene Glycol, Unspecified
- Talc
- Ferric Oxide Yellow /
Pharmaceutical Classes:
- Cytochrome P450 2C8 Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
- Kinase Inhibitor [EPC]
- P-Glycoprotein Inhibitors [MoA]
- Tyrosine Kinase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 51144-002 Tukysa 150 mg Oral Tablet by Seattle Genetics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 51143-966Next: 51144-002 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.